| 000 | 01776 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516181930.0 | ||
| 264 | 0 | _c20140929 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1558-1497 | ||
| 024 | 7 |
_a10.1016/j.neurobiolaging.2013.10.073 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPhillipson, Oliver T | |
| 245 | 0 | 0 |
_aManagement of the aging risk factor for Parkinson's disease. _h[electronic resource] |
| 260 |
_bNeurobiology of aging _cApr 2014 |
||
| 300 |
_a847-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAcetylcarnitine _xadministration & dosage |
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xbiosynthesis |
| 650 | 0 | 4 | _aAging |
| 650 | 0 | 4 | _aAntioxidant Response Elements |
| 650 | 0 | 4 | _aCarbohydrate Metabolism |
| 650 | 0 | 4 | _aElectron Transport |
| 650 | 0 | 4 |
_aEnergy Metabolism _xgenetics |
| 650 | 0 | 4 |
_aFatty Acids _xmetabolism |
| 650 | 0 | 4 |
_aGlial Cell Line-Derived Neurotrophic Factor _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xprevention & control |
| 650 | 0 | 4 |
_aMelatonin _xadministration & dosage |
| 650 | 0 | 4 |
_aMitochondria _xgenetics |
| 650 | 0 | 4 |
_aNitric Oxide _xphysiology |
| 650 | 0 | 4 | _aOxidative Stress |
| 650 | 0 | 4 |
_aParkinson Disease _xetiology |
| 650 | 0 | 4 | _aPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha |
| 650 | 0 | 4 |
_aProteostasis Deficiencies _xprevention & control |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThioctic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aTranscription Factors |
| 650 | 0 | 4 |
_aUbiquinone _xadministration & dosage |
| 650 | 0 | 4 | _aalpha-Synuclein |
| 773 | 0 |
_tNeurobiology of aging _gvol. 35 _gno. 4 _gp. 847-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neurobiolaging.2013.10.073 _zAvailable from publisher's website |
| 999 |
_c23279987 _d23279987 |
||